explore -WSS

explore

author：leisure time 2025-09-06 03:57:39 - browse：85961

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Stem cell treatment guidelines are released by FDA

Wikipedia

WSS

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

US judge blocks portions of new Florida elections law

Noem? Reynolds? A very early look at the Republican 'veepstakes'

focus

explore

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

How to protect patients from sexual assault

BioMarin wins approval for gene therapy to treat hemophilia A

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Walensky prepares to leave CDC — and Congress — behind

Humana sues Biden admin over Medicare Advantage audit rule

BioMarin wins approval for gene therapy to treat hemophilia A

AstraZeneca chief proposes a novel edit to the drug pricing bill

leisure time

4 dead, 2 in stable condition in Philadelphia shooting: Police

Leon Gautier, last member of French D

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Listen: Biogen's potential pivot, & Illumina's next chapter

Leon Gautier, last member of French D

Churchill Downs extends trainer Bob Baffert's ban through 2024

Wikipedia

focus

focus

Wikipedia